large font
change to blue
change to b/w

News

Public Procurement: Medicines procured under the ‘Adult Oncology’ government program are delivered to the regions

1 June 2018
242

Medicines procured for the state budget funds under the ‘Adult Oncology’ government program are currently delivered to the regions. These medicines will be available in health facilities in the nearest future.

 

Adult Oncology

  • Vinorelbine – 912 vials;
  • Doxorubicin – 13 182 vials;
  • Cisplatin 1 mg/ml – 8 077 vials;
  • Cisplatin 0.5 mg/ml – 7 678 vials;
  • Goserelin – 1 278 packs;
  • Docetaxel – 1 945 vials;
  • Oxaliplatin – 2 484 vials;
  • Paclitaxel – 1 184 vials;
  • Fluorouracil – 41 576 packs;
  • Gemcitabine –  2 955 vials;
  • Docetaxel – 3 012 vials;
  • Filhrastim – 448 packs.

The Ministry of Health of Ukraine procures medicines and healthcare products for the funds allocated from the state budget – the amount annually approved by the Verkhovna Rada of Ukraine (UAH 3.4 billion in 2016, UAH 5.9 billion in 2017, and UAH 5.9 billion in 2018). On average, about 45% of the total demand for medicine procurement is covered by the national sources – funds allocated from the state budget.

Medicine procurement through specialized international organizations allows negotiating on prices, and therefore, increasing the purchase volume.

In case when specific medicines are available in stock at hospital, but a patient does not receive it free of charge for any reason, this patient should submit a written notice to the chief physician of this particular health facility or to the local administration / health department, indicating diagnosis with the relevant testing or screening results, and the prescribed medicines.

Order of the Ministry of Health of Ukraine No. 509 stipulates that all health facilities and institutions are obliged to publish information on availability in stock of medicines and healthcare products.

Detailed information about medicine procurement is available in Ukrainian: http://moz.gov.ua/zakupivli-likiv

 

 

Read More